We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Rapid Breath Sensor Detects SARS-CoV-2 from Exhaled Air

By HospiMedica International staff writers
Posted on 18 Aug 2026

Nasal swabs and polymerase chain reaction (PCR) testing have been central to identifying SARS-CoV-2, but they can be uncomfortable, slow, and logistically complex when samples require transport. More...

Point-of-care alternatives that provide immediate results without sample handling could streamline infection control, particularly when patients are most contagious. Noninvasive breath-based testing could further reduce barriers to frequent screening.

Engineers at Northeastern University have developed a handheld gas-sensing device that captures viral particles in a person’s breath and produces near-instant readouts, similar to a Breathalyzer. The platform uses a molecularly imprinted polymer (MIP), a synthetic material molded around a target molecule to form microscopic cavities that selectively capture specific viral particles, including the SARS-CoV-2 spike protein. The sensor combines a silicon base with a graphene layer; when viral particles bind to the MIP cavities, the device’s electrical resistance changes, generating a detectable signal.

The team refined the technology through multiple generations to improve sensitivity and selectivity, enabling the sensor to recognize its target biomarker while largely ignoring other volatile organic compounds in exhaled breath. The device performs best early in infection, when individuals are actively shedding virus, with performance declining as contagiousness decreases. The SARS-CoV-2 application has received a U.S. Patent and Trademark Office patent and has demonstrated high sensitivity and accuracy, although the researchers note that further testing is needed before the technology can be used for clinical diagnosis.

Because the MIP layer can be re-engineered to fit different targets, the same sensing strategy is being adapted for additional analytes. The group mentions ongoing work on sensors for disease-associated particles such as glucose for diabetes and certain RNA molecules relevant to cancer detection, as well as for substances including fentanyl. Larger-scale testing is cited as a next step before any move toward commercialization.

“It's even faster than a swab test and much more user-friendly,” said Nian Sun, distinguished professor of electrical and computer engineering at Northeastern University.

“The beauty of our sensor is that we can readily change our sensors for newly appearing or newly emerging pathogens,” added Sun.

Related Links
Northeastern University 


Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Patient Preoperative Skin Preparation
BD ChloraPrep
Medical-Grade Display
HL2316SHTB
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: 4D flow cardiac MRI images of the pulmonary artery in patients with HFpEF. Left: a patient with normal right ventricle function shows laminar blood flow in the pulmonary artery. Right: a patient with right ventricle dysfunction experiencing turbulent blood flow in the artery. (Image Credit: Farhan Raza and Oliver Wieben)

New Multimodal Framework Targets Debilitating Form of Heart Failure

Heart failure with preserved ejection fraction (HFpEF) occurs when the left ventricle becomes stiff and thickened despite maintaining a normal ejection fraction. The condition is increasingly common with... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.